Survival statistics for brain and spinal cord tumours

Last medical review:

Survival statistics for cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person's chances of survival.

There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for brain and spinal cord tumours and what they mean to you.

Statistics may not be available for rare types of brain and spinal cord tumours.

Net survival

Net survival represents the probability (chance) of surviving cancer in the absence of other causes of death. It is used to give an estimate of the percentage of people who will survive cancer.

In Canada, the 5-year net survival statistic for brain tumours is 19%. This means that, on average, about 19% of people diagnosed with brain tumours will live for at least 5 years.

Spinal cord tumours are included in the category of central nervous system (CNS) tumours, which excludes brain tumours. In Canada, the 5-year net survival for CNS tumours is 61%. This means that, on average, about 61% of people diagnosed with CNS tumours (excluding brain tumours) will live for at least 5 years.

Survival statistics by type of tumour

The following information comes from CONCORD-3, which analyzed the net survival from brain tumours in adults worldwide, including Canada. This study used an older version of the WHO classification system (published in 2016), so the names of the tumours are different than the names in the most recent version of this classification system (published in 2021). Not all types of brain or spinal cord tumours have statistics available.

These statistics cover 5-year net survival in Canada for the most recent period available (2010 to 2014).

5-year net survival for certain brain tumours
Type of tumour 5-year net survival
astrocytoma (grade 2) 60.9%
astrocytoma (grade 3) 26.7%
glioblastoma (grade 4) 10.6%
oligodendroglioma (average of all grades) 58.9%
ependymoma (average of all grades) 65.5%

5-year net survival for glioblastoma by age
Age 5-year net survival
15 to 39 31.4%
40 to 70 7.1%
71 to 99 1.8%

Treatments have improved since 2014, which means that survival rates may be higher for people being diagnosed today.

Survival statistics for other brain and spinal cord tumours

There are no specific Canadian statistics available for the other types of brain and spinal cord tumours.

Meningioma

In the United States, the 5-year net survival for cancerous and benign (non-cancerous) meningioma is between 40% and 84%. Benign tumours have a higher survival rate.

Spinal cord tumours

In the United Kingdom, almost 95% of people diagnosed with a spinal cord tumour will live for 5 years or more. About 90% of people will live 10 years or more.

Questions about survival

People with cancer should talk to their doctor about their prognosis. Prognosis depends on many factors, including:

  • your health history
  • type of cancer
  • stage
  • characteristics of the cancer
  • treatments chosen
  • how the cancer responds to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.

Expert review and references

  • James Perry, MD, FRCPC
  • American Cancer Society. Brain and Spinal Cord Tumors in Adults. Atlanta, GA: American Cancer Society; 2010.
  • Armstrong T. Central nervous system cancer. Yarbro, CH, Wujcki D, & Holmes Gobel B. (eds.). Cancer Nursing: Principles and Practice. 7th ed. Sudbury, MA: Jones and Bartlett; 2011: 49: pp. 1146-1187.
  • Barnholtz-Sloan JS, Sloan AE, & Schwartz AG. Cancer of the brain and other central nervous system. National Cancer Institute. Surveillance Epidemiology and End Results (SEER). Bethesda, MD: National Cancer Institute;
  • Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2021. Canadian Cancer Society; 2021.
  • Minniti G, Brada M, Kleihues P et al. Gliomas. Gospodarowicz, M. K., O'Sullivan, B., Sobin, L. H., et al. (Eds.). Prognostic Factors in Cancer. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2006: 44: pp. 307-310.
  • National Cancer Institute. Adult Brain Tumors Treatment (PDQ®) Health Professional Version. Bethesda, MD: National Cancer Institute; 2010.
  • Preston-Martin S, Munir R, & Chakrabarti, I. Nervous system. Schottenfeld, D. & Fraumeni, J. F. Jr. (eds.). Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 2006: 4.62: pp. 1173-1195.
  • Statistics Canada. Table 13-10-0963-01 Predicted age-standardized and all ages five-year net survival estimates for selected primary types of cancer, by sex, 2019 to 2021. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310096301.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society